Literature DB >> 22577364

Bayesian Regression Models for the Quality Adjusted Lifetime Data with Zero Time Duration Health States.

Kaushal K Mishra1, Sujit K Ghosh.   

Abstract

Clinical trial studies are often conducted in which quality of life is accessed and recorded along with other clinically measurable endpoints. Consideration of the quality of life in addition to the survival time in the statistical analysis can result in better assessment of the treatments being compared. Quality adjusted lifetime (QAL) data analysis can serve as an important tool to the medical and patient community. This article presents a Bayesian regression approach to the modeling of censored QAL data. The Bayesian hierarchical framework based on a progressive health state model with a data augmentation scheme which provides a nonzero probability to the zero time spent in any health state has been developed. Simulation studies using Markov Chain Monte Carlo (MCMC) methods were performed to validate the proposed method. A real data set was used to illustrate the application of the proposed method.

Entities:  

Year:  2011        PMID: 22577364      PMCID: PMC3347487          DOI: 10.1080/15598608.2009.10411939

Source DB:  PubMed          Journal:  J Stat Theory Pract        ISSN: 1559-8608


  7 in total

1.  Joint regression analysis of survival and quality-adjusted survival.

Authors:  J P Fine; R D Gelber
Journal:  Biometrics       Date:  2001-06       Impact factor: 2.571

2.  Locally efficient estimation of the quality-adjusted lifetime distribution with right-censored data and covariates.

Authors:  M J van der Laan; A Hubbard
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

3.  Regression analysis of mean quality-adjusted lifetime with censored data.

Authors:  Hongkun Wang; Hongwei Zhao
Journal:  Biostatistics       Date:  2006-07-28       Impact factor: 5.899

4.  Variance and sample size calculations in quality-of-life--adjusted survival analysis (Q-TWiST).

Authors:  S Murray; B Cole
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

Review 5.  Quality adjusted survival analysis.

Authors:  P P Glasziou; R J Simes; R D Gelber
Journal:  Stat Med       Date:  1990-11       Impact factor: 2.373

6.  Cox regression models for quality adjusted survival analysis.

Authors:  B F Cole; R D Gelber; A Goldhirsch
Journal:  Stat Med       Date:  1993-05-30       Impact factor: 2.373

7.  A quality-of-life-oriented endpoint for comparing therapies.

Authors:  R D Gelber; R S Gelman; A Goldhirsch
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.